Canada markets open in 4 hours 44 minutes

NuGen Medical Devices Inc. (NGMD.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.10500.0000 (0.00%)
At close: 03:59PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 20.90M
Enterprise Value 26.68M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)79.26
Price/Book (mrq)N/A
Enterprise Value/Revenue 144.45
Enterprise Value/EBITDA -4.09

Trading Information

Stock Price History

Beta (5Y Monthly) 2.73
52-Week Change 3-52.27%
S&P500 52-Week Change 323.57%
52 Week High 30.2550
52 Week Low 30.0900
50-Day Moving Average 30.1199
200-Day Moving Average 30.1227

Share Statistics

Avg Vol (3 month) 3356.82k
Avg Vol (10 day) 3143.49k
Shares Outstanding 5199.03M
Implied Shares Outstanding 6199.03M
Float 8182.58M
% Held by Insiders 17.91%
% Held by Institutions 10.00%
Shares Short (Apr 15, 2024) 485.75k
Short Ratio (Apr 15, 2024) 40.4
Short % of Float (Apr 15, 2024) 4N/A
Short % of Shares Outstanding (Apr 15, 2024) 40.03%
Shares Short (prior month Mar 15, 2024) 4842.49k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,810.03%

Management Effectiveness

Return on Assets (ttm)-60.04%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)184.71k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)2,775.30%
Gross Profit (ttm)N/A
EBITDA -6.63M
Net Income Avi to Common (ttm)-8.53M
Diluted EPS (ttm)-0.0600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.67M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)7.45M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.90
Book Value Per Share (mrq)-0.00

Cash Flow Statement

Operating Cash Flow (ttm)-5.67M
Levered Free Cash Flow (ttm)-3.76M